- Report
- August 2024
- 175 Pages
Global
From €4780EUR$5,000USD£4,002GBP
- Report
- January 2024
- 77 Pages
Global
From €3500EUR$3,921USD£3,032GBP
Tobramycin eye drops are a topical antibiotic solution used to treat bacterial infections of the eye, such as conjunctivitis and keratitis. As part of the aminoglycoside antibiotics class, tobramycin works by inhibiting the production of proteins essential for the survival of bacteria, leading to their death. The medication is typically prescribed for ocular infections caused by susceptible strains of gram-negative and gram-positive bacteria. Tobramycin eye drops are often indicated by doctors when an infection is diagnosed or suspected to be bacterial in nature and is less effective against viral or fungal eye infections. The market for tobramycin eye drops includes prescription treatments as well as combinations with other drugs, like corticosteroids for treating inflammation associated with infections.
The therapeutic effectiveness, together with the need for treatments against bacterial eye infections, shapes the demand for tobramycin eye drop formulations in the antibiotic segment. There are various manufacturers and pharmaceutical companies that offer tobramycin eye drops, often as a generic medication due to the expiration of the original patent. Some leading companies in the market include Novartis (under its subsidiary Sandoz), Allergan, Pfizer, and Apotex. These pharmaceutical companies distribute tobramycin eye drops worldwide, catering to both mature and emerging markets, and operate under regulations that assure the safety, quality, and efficacy of their products. Show Less Read more